Investigators from Montefiore developed a novel combination that has now demonstrated early-stage efficacy in metastatic lung cancer.
Everolimus demonstrated strong potential as an effective tool for overcoming endocrine resistance in postmenopausal women with ER-positive, HER2-negative metastatic breast cancer resistant to AI therapy.
Investigators to present findings on Spine, Lung, Liver and Head and Neck Cancer Research at the 59th Annual ASTRO Meeting.
For the past 5 years, Montefiore has been a leading Pioneer Accountable Care Organization (ACO) in CMS’ ACO program, which aims to improve the quality of care for Medicare beneficiaries while identifying ways to save healthcare dollars.
Breast cancer related lymphedema, a common and painful, yet underreported side effect of surgery and radiation, is getting fresh attention, courtesy of new guidelines from internationally recognized breast surgeons.